Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001079973-24-001750
Filing Date
2024-12-23
Accepted
2024-12-23 11:59:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4625
  Complete submission text file 0001079973-24-001750.txt   6173
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Subject) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-85836 | Film No.: 241571514
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address KAISER-FRIEDRICH-ALLEE 2 AACHEN 2M 52074
Business Address
Schornstein Alexander (Filed by) CIK: 0001999256 (see all company filings)

Type: SCHEDULE 13G